Delivery Order SPE2DB22D1106-SPE2DB25FEWE4
Award Date
7/2/25
Potential Completion Date
7/3/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $10,459.32 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Medroxyprogesterone 150 mg/mL. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,584.08 firm-fixed-price delivery order is for the supply of 4566764107 MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a period of performance through December 20, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,659.02, is for the delivery of Medroxyprogesterone 150 mg/mL, a pharmaceutical product. The contract has a delivery order type and firm fixed price pricing structure, with a performance period ending on May 22, 2023. The contract is not designated as a set-aside and was awarded through full and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,144.95 and is a delivery order with a firm fixed price. The contract covers the supply of MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a period of performance through May 20, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,192.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of medroxyprogesterone 150 mg/ml, a pharmaceutical product, to support federal healthcare programs. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Medroxyprogesterone 150 mg/mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,177.00, is a firm fixed-price delivery order with a performance period ending on May 2, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,814.73 Firm Fixed Price Delivery Order contract is for the delivery of 4560732397 MEDROXYPROGESTERONE 150 MG/ML products. The award is associated with a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, SPE2DB20D3505|SPE2DB25FT7F2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,254.68 firm fixed-price delivery order is for the supply of MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a completion date of January 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,189.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566188922 - MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 24, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $15,045.76 firm fixed-price delivery order is for the supply of Medroxyprogesterone 150 mg/ml, a pharmaceutical product. The contract has a completion date of September 12, 2024 and is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to various government agencies and...